Core Laboratories NV logo

CLB - Core Laboratories NV News Story

$27.19 0.2  0.9%

Last Trade - 24/09/21

Mid Cap
Market Cap £920.7m
Enterprise Value £1.05bn
Revenue £326.2m
Position in Universe 2746th / 7172

Core Laboratories NV reports results for the quarter ended in June - Earnings Summary

Thu 29th July, 2021 6:43am
* Core Laboratories NV  CLB.N  reported quarterly adjusted
earnings of 18 cents​​ per share for the quarter ended in June.
The mean expectation of ten analysts for the quarter was
for earnings of 19 cents per share.
* Revenue rose 2.6% to $118.75 million from a year ago; 
analysts expected $119.28 million. 
* Core Laboratories NV's reported EPS for the quarter was 17
* The mean earnings estimate of analysts had fallen by
about 4.5% in the last three months.​ 
* In the last 30 days one analyst negatively revised an earnings
* Core Laboratories NV shares had fallen by 9.7% this
quarter and gained 32.6% so far this year.
* The company reported quarterly net income of $8.06 million.
* Wall Street's median 12-month price target for Core
Laboratories NV is $33.00 
* The current average analyst rating on the shares is "hold" and
the breakdown of recommendations is 3 "strong buy" or "buy," 8
"hold" and 1 "sell" or "strong sell." 
This summary was machine generated July 29 at 05:43 a.m.  ​All
figures in US dollars unless otherwise stated
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.